<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical and serological findings in 13 patients with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (the '<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>', antibodies to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, antibodies to <z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi> (one patient] seen by our unit and other units from 1984 to 1989, are presented (eight males and five females, ages ranging from 20 to 52 years) </plain></SENT>
<SENT sid="1" pm="."><plain>Five suffered <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> before the age of 30; four of these five were in their early 20s </plain></SENT>
<SENT sid="2" pm="."><plain>Other risk factors such as excessive smoking (greater than 20 cigarettes a day) (two patients), long-term treatment with steroid (one) and use of oral contraceptives (one) were present </plain></SENT>
<SENT sid="3" pm="."><plain>One patient had demonstrated a plasminogen activator deficiency and one a deficiency of protein C </plain></SENT>
<SENT sid="4" pm="."><plain>Two patients developed <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> six to eight weeks after <z:chebi fb="8" ids="10033">warfarin</z:chebi> was discontinued for <z:hpo ids='HP_0004850'>recurrent deep vein thrombosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Six patients had SLE as defined by the revised 1982 criteria, three suffered from '<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like' disease, while four patients conformed to a 'primary' <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>